SH
SHWZ.US Medicine Man Technologies Inc
- Market cap
- USD 802.00
- P/E
- -
- P/B
- -
- ROE
- -66.1%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2024.
Is SHWZ.US undervalued?
Graham numberThe Graham number of Medicine Man Technologies Inc cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Medicine Man Technologies Inc fundamental analysis
No fundamental analysis for Medicine Man Technologies Inc yet.
Medicine Man Technologies Inc stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Medicine Man Technologies Inc
Medicine Man Technologies, Inc., doing business as Schwazze, engages in the cultivation, manufacturing, distribution, and retail sale of cannabis and cannabis related products in Colorado and New Mexico. It operates through Retail, Wholesale, and Others segments. The company offers loose flower, concentrates, edibles, pre-rolls, topicals, infused beverages, and other associated cannabis products produced by cannabis vendors; and cannabis and non-cannabis products. It operate…
Full company profileMedicine Man Technologies Inc financial statements
2024 annualized: Fiscal year 2024 is not finished. Income statement and cash flow are annualized from 2 quarters up to Jun 30, 2024, the balance sheet is the latest quarter. Figures change when the annual report is published.
Medicine Man Technologies Inc annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 252K | 836K | 631K | 3.53M | 7.92M | 10.6M | 24.0M | 108M | 159M | 172M | 170M |
| Gross Profit | 180K | 626K | 169K | 2.23M | 5.35M | 3.00M | 6.77M | 49.4M | 85.0M | 76.0M | 74.0M |
| Operating Income | -28.8K | 90.2K | -1.15M | -5.24M | 2.17M | -13.5M | -22.9M | 10.4M | 12.9M | 3.29M | -10.9M |
| EBITDA | -30.4K | 96.8K | -1.42M | -5.23M | 1.61M | -13.4M | -19.8M | 34.5M | 37.2M | 38.2M | 13.4M |
| Net Income | -30.0K | 85.7K | -1.46M | -5.38M | 949K | -17.0M | -19.4M | 14.5M | -18.5M | -34.5M | -60.0M |
| EPS | 0.00 | 0.01 | -0.14 | -0.23 | 0.03 | -0.50 | -0.47 | 0.34 | -0.34 | -0.54 | -0.76 |
| Balance Sheet | |||||||||||
| Total Assets | 312K | 477K | 728K | 11.1M | 18.2M | 32.2M | 70.7M | 285M | 323M | 358M | 340M |
| Total Liabilities | 22.8K | 21.9K | 1.10M | 393K | 1.15M | 5.65M | 28.9M | 151M | 191M | 239M | 249M |
| Shareholders' Equity | 290K | 455K | -376K | 10.7M | 17.1M | 26.6M | 41.8M | 134M | 132M | 119M | 90.8M |
| Cash & Short-term Investments | 54.5K | 302K | 366K | 749K | 322K | 11.9M | 1.23M | 106M | 39.4M | 19.7M | 12.4M |
| Total Debt | - | - | 810K | 58.3K | - | 66.8K | 21.5M | 106M | 148M | 192M | 198M |
| Cash Flow | |||||||||||
| Operating Cash Flow | -205K | 302K | -741K | -674K | 1.29M | -7.55M | -9.80M | 57.3M | 11.4M | 12.2M | -7.62M |
| Capital Expenditure | 0.00 | 54.2K | 10.8K | 256K | 20.0K | 200K | 768K | 5.67M | 14.8M | 10.6M | 4.30M |
| Free Cash Flow | -205K | 248K | -752K | -930K | 1.27M | -7.75M | -10.6M | 51.7M | -3.42M | 1.59M | -11.9M |
| Ratios | |||||||||||
| ROE | -10.3% | 18.8% | - | -50.1% | 5.6% | -63.9% | -46.5% | 10.9% | -14.0% | -29.0% | -66.1% |
| ROA | -9.6% | 18.0% | -201.2% | -48.3% | 5.2% | -52.7% | -27.5% | 5.1% | -5.7% | -9.6% | -17.7% |
| Net Profit Margin | -11.9% | 10.3% | -231.9% | -152.5% | 12.0% | -159.9% | -80.9% | 13.4% | -11.6% | -20.0% | -35.3% |
| Debt to Equity | - | - | - | 0.01x | - | 0.00x | 0.52x | 0.80x | 1.12x | 1.61x | 2.18x |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Medicine Man Technologies Inc dividends
Medicine Man Technologies Inc has not paid dividends in the last 9 fiscal years.
Who owns Medicine Man Technologies Inc
- Insiders 0.00%
- Institutions 0.50%
- Public & others 99.50%
- Shares outstanding 80.2M
- Free float 67.1M
Medicine Man Technologies Inc company profile
- Company name
- Medicine Man Technologies Inc
- Ticker
- SHWZ.US
- Exchange
- USA Stocks
- Sector
- Healthcare
- Industry
- Pharmaceuticals
- Employees
- 729
- Fiscal year end
- December
- Address
- 865 North Albion Street, Denver, CO, United States, 80220
- Phone
- 303 371 0387
- Website
- schwazze.com
About Medicine Man Technologies Inc
Medicine Man Technologies, Inc., doing business as Schwazze, engages in the cultivation, manufacturing, distribution, and retail sale of cannabis and cannabis related products in Colorado and New Mexico. It operates through Retail, Wholesale, and Others segments. The company offers loose flower, concentrates, edibles, pre-rolls, topicals, infused beverages, and other associated cannabis products produced by cannabis vendors; and cannabis and non-cannabis products. It operates retail cannabis dispensaries under the Star Buds, Emerald Fields, Standing Akimbo, Everest Cannabis Co., and R. Greenleaf brand names. In addition, the company sells indoor gardening supplies and hydroponics through its online and retail store. Medicine Man Technologies, Inc. was incorporated in 2014 and is headquartered in Denver, Colorado.
Medicine Man Technologies Inc management
10- Mr. Forrest HoffmasterChief Executive Officer
- Mr. Philippe FarautInterim Chief Financial Officer · born 1970
- Ms. Christine JonesChief Legal Officer & Corporate Secretary · born 1965
- Mr. Dan BonachVice President of Human Resources
- Mr. Todd WilliamsExecutive Vice President of M&A and Real Estate
- Mr. Christopher Lee DriessenExecutive Vice President of Commercial Sales
- Mr. Collin LodgePresident of Colorado Division
- Mr. David KaufmanExecutive Vice President of Integrated Supply Chain
- Ed EissenstatVP of Information Technology & C.I.O
- Rebecca TerryController